Relapse

HIGHLIGHTS

• who: Targeting acetylcholine signaling modulates and colleagues from the SchoolTsinghua University Texas Southwestern Medical Center, Dallas, USA have published the paper: relapse, in the Journal: (JOURNAL)
• what: Taken together, the study provides a perspective for the design of more effective and personalized intervention strategies for patients receiving EGFR-TKI therapy.
• how: The authors analyzed the public chromatin immunoprecipitation-sequencing (ChIP-seq) data from the previous studies related to drug tolerance and multiple human cell lines which were integrated by ChIP-Atlas finding 3 potential YAP-binding_sites in the distal regulatory regions of ChAT . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.